Page last updated: 2024-09-05

nk3201 and angiotensin i

nk3201 has been researched along with angiotensin i in 1 studies

Compound Research Comparison

Studies
(nk3201)
Trials
(nk3201)
Recent Studies (post-2010)
(nk3201)
Studies
(angiotensin i)
Trials
(angiotensin i)
Recent Studies (post-2010) (angiotensin i)
18014,2181251,253

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sukenaga, Y; Takai, S; Yuda, A1

Other Studies

1 other study(ies) available for nk3201 and angiotensin i

ArticleYear
Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.
    Life sciences, 2001, Aug-31, Volume: 69, Issue:15

    Topics: Acetamides; Administration, Oral; Angiotensin I; Animals; Carotid Arteries; Cell Division; Chymases; Culture Techniques; Dogs; Drug Antagonism; Graft Occlusion, Vascular; Muscle Contraction; Peptidyl-Dipeptidase A; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Veins

2001